{"page_content": "85\n\ufffdntroduction Access and Global Health Our People Environment Community Management Disclosure and Data Appendix GR\ufffd, SASB and TCFD\n2022 Viatris Sustainability Report\nInternational nonproprietary name (INN) Dosage form & strength\nSofosbuvir Tablet, Film-coated 400mg\nDaclatasvir (dihydrochloride) Tablet, Film-coated 60mg\nDaclatasvir (dihydrochloride)/Sofosbuvir Tablet, Film-coated 60mg/400mg\nSofosbuvir/Velpatasvir Tablet, Film-coated 400mg/100mg\nAtazanavir (sulfate) Capsules, hard 150mg\nAtazanavir (sulfate) Capsules, hard 300mg\nLamivudine Tablet 300mg\nAbacavir (sulfate) Tablet 300mg\nZidovudine Tablet 300mg\nAbacavir (sulfate)/Lamivudine/Zidovudine Tablet 300mg/150mg/300mg\nLamivudine/Zidovudine Tablet, Film-coated 150mg/300mg\nEfavirenz Tablet, Film-coated 600mg\nTenofovir disoproxil fumarate Tablet, Film-coated 300mg\nLamivudine/Tenofovir disoproxil fumarate Tablet, Film-coated 300mg/300mg\nEmtricitabine/Tenofovir disoproxil fumarate Tablet, Film-coated 200mg/300mg\nLamivudine/Nevirapine/Zidovudine Tablet, Film-coated 150mg/200mg/300mg\nLamivudine/Nevirapine/Zidovudine Tablet, Dispersible 30mg/50mg/60mg\nEfavirenz/Emtricitabine/Tenofovir disoproxil \nfumarateTablet, Film-coated 600mg/200mg/300mg\nEfavirenz/Emtricitabine/Tenofovir disoproxil \nfumarateTablet, Film-coated 600mg/300mg/300mg\nRitonavir Tablet, Film-coated 100mgInternational nonproprietary name (INN) Dosage form & strength\nLamivudine/Zidovudine Tablet, Dispersible 30mg/60mg\nRitonavir Tablet, Film-coated 25mg\nAbacavir (sulfate)/Lamivudine Tablet, Film-coated 600mg/300mg\nDolutegravir (Sodium) Tablet, Film-coated 50mg\nDarunavir (ethanolate) Tablet, Film-coated 800mg\nDarunavir (ethanolate) Tablet, Film-coated 600mg\nSulfamethoxazole/Trimethoprim Tablet 400mg/80mg\nSulfamethoxazole/Trimethoprim Tablet 800mg/160mg\nDolutegravir (Sodium)/Lamivudine/Tenofovir \ndisoproxil fumarateTablet, Film-coated 50mg/300mg/300mg\nFlucytosine Tablet 500mg\nLopinavir/Ritonavir Granules for Oral suspension 40mg/10mg\nEfavirenz/Lamivudine/Tenofovir disoproxil \nfumarateTablet, Film-coated 400mg/300mg/300mg\nFlucytosine Tablet 250mg\nFlucytosine Tablet 500mg\nIsoniazid/Pyridoxine hydrochloride /\nSulfamethoxazole/TrimethoprimTablet, Film-coated \n300mg/25mg/800mg/160mg\nDolutegravir (Sodium) Tablet, Dispersible 10mg\nEfavirenz Tablet 50mg\nEfavirenz Tablet, Film-coated 100mg\nEfavirenz Tablet 200mgProducts on the WHO Prequalification list\nWHO Pre-Qualification list as per 1/3/2023SourcesTherapeutic  \nArea LegendHepatitis Influenza Reproductive Oncology\nHIV/AIDS Malaria Tuberculosis", "metadata": {"source": "NASDAQ_VTRS_2022.pdf", "page": 84, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}